Medigene AG (HAM:MDG1) FCF Margin %: -337.09% (As of Jun. 2024)


HAM:MDG1 Medigene AG HAM:MDG1
12 GF Score
Price €0.02
View Full Analysis

What is Medigene AG FCF Margin %?

Medigene AG HAM:MDG1 12 FCF Margin % is -337.09% as of Jun. 2024. GuruFocus rates HAM:MDG1 with a GF Score™ of 12/100.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Medigene AG's Free Cash Flow for the six months ended in Jun. 2024 was €-15.09 Mil. Medigene AG's Revenue for the six months ended in Jun. 2024 was €4.48 Mil. Therefore, Medigene AG's FCF Margin % for the quarter that ended in Jun. 2024 was -337.09%.

As of today, Medigene AG's current FCF Yield % is 0.00%.

The historical rank and industry rank for Medigene AG's FCF Margin % or its related term are showing as below:

HAM:MDG1' s FCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -300.73

HAM:MDG1's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -84.65 vs HAM:MDG1: -300.73

Medigene AG FCF Margin % Related Terms

Medigene AG FCF Margin % Historical Data

* Premium members only.

The historical data trend for Medigene AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medigene AG FCF Margin % Chart

Medigene AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -167.90 -315.80 -103.98 35.10 -261.57

Medigene AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.52 -102.35 -276.73 -245.93 -337.09

HAM:MDG1 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Medigene AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigene AG FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigene AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Medigene AG's FCF Margin % falls into.


HAM:MDG1
12GF Score
Medigene AG HAM:MDG1
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medigene AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Medigene AG's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-15.783/6.034
=-261.57 %

Medigene AG's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-15.088/4.476
=-337.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -337.09% mean?
Medigene AG (HAM:MDG1) has a FCF Margin % of -337.09% as of Jun. 2024. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medigene AG and its competitors.
Is Medigene AG's FCF Margin % too high?
Medigene AG's current FCF Margin % is -337.09%. Overall, Medigene AG has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Medigene AG's FCF Margin % compare to VRTX and REGN?
Medigene AG's FCF Margin % of -337.09% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medigene AG and its competitors. Medigene AG's current FCF Margin % is -337.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medigene AG stock overvalued right now?
Medigene AG (HAM:MDG1) has a current FCF Margin % of -337.09%. The current FCF Margin % is -337.09%. Medigene AG's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Medigene AG (HAM:MDG1), the current FCF Margin % is -337.09% as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medigene AG Business Description

Address Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152
Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.
12GF Score

Get the complete analysis for HAM:MDG1

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price